🔍 Intelligence Synthesis JP/EN
Ethics · Regulation · Technology — Pharma Practice Notes

AI and the Pharmaceutical Industry — 2026-11-16 (Mon)

Daily ReportPast 24h · aggregated 02:20 JST·0 items

This section covers corporate investment behaviour of pharmaceutical companies, not the efficacy or safety of any medicinal product. Headlines are quoted as published; no claim about product performance is made or implied by this site. Collection and classification are automated and may misclassify or miss items. Disclaimer

Harvested 219Accepted 0Stale 112Duplicate 13Low-quality source 18Market noise 3Market research 0Off-topic 64No investment signal 8
💰 Investment MapAmounts are extracted from source text by pattern matching only. No currency conversion.
AmountDealFunctionSource
$20 millionThis drug-development startup raised about $20 million; now its team builds OpenAI's life-sciences AI; her🏛️ Enterprise AI Platform & GovernanceThe Economic Times
🧬 Drug Discovery0
No items today · See past 90 days →
🧪 Clinical Development0
No items today · See past 90 days →
📑 CTD / Regulatory Submission0
No items today · See past 90 days →
🩺 GCP Operations0
No items today · See past 90 days →
📘 ICH Guidelines & AI0
No items today · See past 90 days →
🛡️ Pharmacovigilance / GVP0
No items today · See past 90 days →
📊 RWE / Evidence Generation0
No items today · See past 90 days →
🎓 Medical Affairs0
No items today · See past 90 days →
💼 Sales0
No items today · See past 90 days →
📣 Marketing0
No items today · See past 90 days →
🚚 Distribution / Supply Chain0
No items today · See past 90 days →
✅ GQP / Quality Assurance0
No items today · See past 90 days →
👥 Human Resources0
No items today · See past 90 days →
💴 Finance & Accounting0
No items today · See past 90 days →
🏛️ Enterprise AI Platform & Governance0
No items today · See past 90 days →
← 2026-11-15Index2026-11-17 →
← AI and the Pharmaceutical Industry — index